Article Contents ::
Details About Generic Salt :: Alendronate
Main Medicine Class:: Endocrine,Steroid Hormones , Metabolic System Sub Medicine Class :: Drugs affecting Bone Metabolism
| 8I. DRUGS AFFECTING BONE METABOLISM in 8. ENDOCRINE/STEROID HORMONES & METABOLIC SYSTEM |
| ALENDRONATE |
| AMINOBISPHOSPHONATE | BONE RESORPTION INHIBITOR |
| PK: A: Poor D: 28 L (exclusive of bone) M: None E: Urine & feces |
|
Indications & Dose: COMPLEX REGIONAL PAIN SYNDROME IV Adult 7.5mg/day 3 days | CORTICOSTEROID-INDUCED OSTEOPOROSIS PO Adult 5mg/day, in postmenopausal women not receiving HRT administer 10mg/day | PAGET’S DISEASE OF BONE PO Adult 40mg/day 6 months, may repeat if necessary after an interval of a further 6 months | POSTMENOPAUSAL OSTEOPOROSIS Prophylactic therapy PO Adult 5mg/day | POSTMENOPAUSAL OSTEOPOROSIS & OSTEOPOROSIS IN MEN PO Adult 10mg/day |
| Contra: Hypersensitivity, hypocalcemia, oesophagus abnormalities
Precautions: Upper GI disorders, disturbances of Ca & mineral metabolism, renal impairment ADR: Serious: SJS, TEN, peptic ulceration, angioedema, atypical stress fractures, decrease electrolyte levels, gastritis, myalgia, Others: malaise, fever, abdominal pain, dyspepsia, regurgitation, nausea, vomiting, diarrhea, constipation, flatulence, headache DDI: Serious Naproxen causes gastric mucosal damage, Antacids reduces drug absorption Diet: Before food Monitor: Osteoporosis, annual measurements of height/weight, chronic back pain & Serum Calcium |
